Woodline Partners’s Rapport Therapeutics RAPP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.1M Buy
185,028
+3,000
+2% +$34.1K 0.01% 717
2025
Q1
$1.83M Buy
182,028
+498
+0.3% +$5K 0.01% 682
2024
Q4
$3.22M Sell
181,530
-5,030
-3% -$89.2K 0.02% 574
2024
Q3
$3.82M Buy
186,560
+15,460
+9% +$317K 0.03% 417
2024
Q2
$3.98M Buy
+171,100
New +$3.98M 0.04% 361